Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial

Autor: Pierre Malchair, Jordi Giol, Vanesa García, Orlando Rodríguez, José Carlos Ruibal, Alvaro Zarauza, Ferrán Llopis, Leire Matellán, Tania Bernal, Beatriz Solís, Aurema Otero, Thiago Carnaval, Hector Jofre, Javier Jacob, Xavier Solanich, Arnau Antolí, Gemma Rocamora, Sebastián Videla

Publikováno v: Clinical Infectious Diseases. 76:1784-1792

Background We aimed to evaluate icatibant, a competitive antagonist of the bradykinin B2 receptors, for the treatment of inpatients with coronavirus disease 2019 (COVID-19) pneumonia admitted in the early hypoxemic stage. Methods The randomized, open

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df34c05a30914fbe719b4a00564f35d6
https://doi.org/10.1093/cid/ciac984

Suspected adverse events following immunization against SARS-CoV2 in a university hospital in 2021: Observational study

Autor: Dolores Rodríguez, Pilar Ordoñez, Roser Llop, Sebastián Videla, Aurema Otero, Thiago Carnaval, Violeta Poltorak, Miguel Moya-Guerola, Cristina Masuet-Aumatell, Soledad Rodriguez, Pilar Hereu

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona

Aim: Vaccination against SARS-CoV2 has been proposed as a fundamental element for the control of the pandemic. This study aimed to describe the suspected adverse reactions (ADR) reported by vaccinated hospital workers. Methods: A descriptive study of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2475558cf54eb62523fc62e7cf2ce7
https://pubmed.ncbi.nlm.nih.gov/36254083

Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT·COVID): a randomized, open-label, phase 2, proof-of-concept trial

Autor: Pierre, Malchair, Jordi, Giol, Vanesa, García, Orlando, Rodríguez, José Carlos, Ruibal, Alvaro, Zarauza, Ferrán, Llopis, Leire, Matellán, Tania, Bernal, Beatriz, Solís, Aurema, Otero, Thiago, Carnaval, Hector, Jofre, Javier, Jacob, Xavier, Solanich, Arnau, Antolí, Gemma, Rocamora, Sebastián, Videla, Xavier, Corbella

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

We aimed to evaluate icatibant, a competitive antagonist of the bradykinin B2 receptors, for the treatment of inpatients with COVID-19 pneumonia admitted in the early hypoxemic stage.The randomized, open-label clinical trial of icatibant for COVID-19

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dea8521b02cca3f119cc89c635bedaf5
https://pubmed.ncbi.nlm.nih.gov/36610464

Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function

Autor: Pablo Moreno-Llorente, Arantxa García-Barrasa, Mireia Pascua-Solé, Sebastián Videla, Aurema Otero, José Luis Muñoz-de Nova

Publikováno v: World journal of surgery. 47(2)

Hypoparathyroidism is the most frequent complication after total thyroidectomy and, when permanent, it becomes a severe chronic disease. We assessed the usefulness of indocyanine green (ICG) angiography-guided thyroidectomy to reduce the postoperativ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332e2f6c90e9a658c53531d2406596eb
https://pubmed.ncbi.nlm.nih.gov/35945357

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Autor: Andrea Alemany, Pere Millat-Martinez, Marc Corbacho-Monné, Pierre Malchair, Dan Ouchi, Anna Ruiz-Comellas, Anna Ramírez-Morros, Joana Rodríguez Codina, Rosa Amado Simon, Sebastian Videla, Gèlia Costes, Mar Capdevila-Jáuregui, Pamela Torrano-Soler, Alba San José, Glòria Bonet Papell, Jordi Puig, Aurema Otero, Jose Carlos Ruibal Suarez, Alvaro Zarauza Pellejero, Ferran Llopis Roca, Orlando Rodriguez Cortez, Vanesa Garcia Garcia, Josep Vidal-Alaball, Anna Millan, Enric Contreras, Joan-Ramon Grifols, Àgueda Ancochea, Ivan Galvan-Femenia, Francini Piccolo Ferreira, Mireia Bonet, Jordi Cantoni, Núria Prat, Jordi Ara, Anna Forcada Arcarons, Magí Farré, Edwards Pradenas, Julià Blanco, Miquel Àngel Rodriguez-Arias, Gema Fernández Rivas, Michael Marks, Quique Bassat, Ignacio Blanco, Bàrbara Baro, Bonaventura Clotet, Oriol Mitjà, Susana Ferrer, Mireia Gallardo, Maria Ubals, Camila González-Beiras, Martí Vall-Mayans, Clara Suñer, Clàudia Laporte-Villar, Aroa Nieto, Xavier Comas-Leon, Zahida Jiménez, Ferran Ramírez-Viaplana, Maria Delgado-Capel, Beatriz Díez Sánchez, Maria Pons Barber, Cristian Gonzalez Ruiz, Laura Navarrete Gonzalez, David González García, Ainhoa Vivero Larraza, Victor Carceles Peiró, Clàudia Roquer López, Neus Robert, Carles Palet, Carlota Gudiol, Pablo Casares Gonzalez, Gemma Arcos Vila, Begoña Flores Aguilera, Graciela Rodríguez-Sevilla, Macarena Dastis Arias, Judit Roca Font, Katherine M. Carrasco Matos, Glòria Saüch Valmaña, Carla Vidal Obradors, Silvia Tarres García, Margarida Curriu Sabatès, Raquel Nieto Rodríguez, Rosa Línio, Míriam Fornos, Natàlia Casamitjana, Eva Alonso, Núria Martínez, Laura Analía Maglio, Laura Comellas Fernandez, Nadia Garcia, Luis Hernández, Maria Isabel González, Anna Bravo, Yolanda García, Silvia Sauleda Oliveras, Tatiana Vertiz, Sergio Benavent, Andrea Sofia Bianco, Joaquim Verdaguer, Ney Nicanor Briones Zambrano, Maria Viozquez Meya, Águeda Hernández, Cristina Casaña Lopez, Antoni E. Bordoy, Victoria González Soler, Montserrat Giménez, Alexa París, Silvia Marfil, Benjamin Trinité, Eulàlia Grau

Publikováno v: LANCET RESPIRATORY MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares

BACKGROUND: Convalescent plasma has been proposed as an early treatment to interrupt the progression of early COVID-19 to severe disease, but there is little definitive evidence. We aimed to assess whether early treatment with convalescent plasma red

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d2ead4de30d17fe2d10e7eb35ad97c
https://pubmed.ncbi.nlm.nih.gov/35150608